A minimally invasive brain surgery, frame-based
stereotactic craniotomy involves the use of computed tomography or magnetic
resonance imaging in order to locate a brain lesion before a craniotomy. A
metal frame placed around the head is used to identify the lesions in relation
to the frame, and then a three-dimensional map of the brain is produced in
order to identify the best path to dissect the lesion.
Also
Known As:
- Craniotomy
- Brain surgery
- Brain
tomography
- Stereotactic
brain biopsy
- Stereotactic
brain surgery
- Stereotactic
neurosurgery
Conditions
Treated with Frame-Based Stereotactic Craniotomy:
Frame-based stereotactic craniotomy may be performed
in cases of abnormal blood vessels, brain tumors, Parkinson’s disease and when
a biopsy is needed.
There are no comparable non-surgical alternatives to
frame-based stereotactic craniotomy. Frameless stereotactic craniotomy is a
surgical alternative to the procedure.
Anesthesia
with Frame-Based Stereotactic Craniotomy:
Frame-based stereotactic craniotomy is performed
under general anesthesia, which means that the patient is asleep and completely
unaware during the procedure.
Potential
Complications from Frame-Based Stereotactic Craniotomy:
Possible risks following frame-based stereotactic
craniotomy include infection, brain damage, hemorrhage, brain swelling,
seizures, cerebral vasospasm and a negative reaction to the anesthesia. It is
also possible to experience stroke and coma.
Recovery
from Frame-Based Stereotactic Craniotomy:
Total recovery from frame-based stereotactic
craniotomy takes one to four weeks.